We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+74.55%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$611M
AUM Growth
+$189M
Cap. Flow
+$13.6M
Cap. Flow %
2.23%
Top 10 Hldgs %
10.32%
Holding
440
New
177
Increased
32
Reduced
81
Closed
148

Top Buys

Rank Stock Value
1
CALY
Callaway Golf Company
CALY
+$6.91M
2
GNTX icon
Gentex
GNTX
+$6.43M
3
APAM icon
Artisan Partners
APAM
+$5.25M
4
SSTK icon
Shutterstock
SSTK
+$5.01M
5
VCEL icon
Vericel Corp
VCEL
+$3.84M

Top Sells

Rank Stock Value
1
CRDF icon
Cardiff Oncology
CRDF
+$5.05M
2
WKHS icon
Workhorse Group
WKHS
+$4.62M
3
CYRX icon
CryoPort
CYRX
+$4.55M
4
SITM icon
SiTime
SITM
+$3.83M
5
MCRB icon
Seres Therapeutics
MCRB
+$3.78M

Sector Composition

Rank Sector Weight
1 Healthcare 26%
2 Technology 24.89%
3 Consumer Discretionary 15.91%
4 Industrials 14.11%
5 Financials 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLDR icon
126
Builders FirstSource
BLDR
$8.02B
$1.96M 0.32%
47,905
-5,398
-10% -$191K
SONO icon
127
Sonos
SONO
$1.85B
$1.94M 0.32%
+82,727
New +$1.54M
BEAM icon
128
Beam Therapeutics
BEAM
$2.8B
$1.93M 0.32%
+23,642
New +$1.16M
LNW
129
DELISTED
Light & Wonder
LNW
$1.92M 0.31%
46,298
+4,372
+10% +$161K
MED icon
130
Medifast
MED
$142M
$1.92M 0.31%
+9,780
New +$1.73M
MKSI icon
131
MKS Inc
MKSI
$20.6B
$1.91M 0.31%
+12,697
New +$1.66M
KURA icon
132
Kura Oncology
KURA
$840M
$1.91M 0.31%
58,409
-86,213
-60% -$3.03M
SMAR
133
DELISTED
Smartsheet Inc.
SMAR
$1.9M 0.31%
+27,443
New +$1.61M
BLFS icon
134
BioLife Solutions
BLFS
$1.67B
$1.9M 0.31%
47,636
-6,038
-11% -$206K
TKR icon
135
Timken Company
TKR
$8.97B
$1.89M 0.31%
+24,470
New +$1.67M
LOVE
136
LoveSac
LOVE
$257M
$1.89M 0.31%
+43,875
New +$1.45M
UTZ icon
137
Utz Brands
UTZ
$1.25B
$1.89M 0.31%
85,563
+8,138
+11% +$155K
AHCO icon
138
AdaptHealth
AHCO
$783M
$1.88M 0.31%
+50,091
New +$1.55M
AIMC
139
DELISTED
Altra Industrial Motion Corp
AIMC
$1.88M 0.31%
+33,936
New +$1.67M
CDMO
140
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.88M 0.31%
+162,614
New +$1.49M
LDL
141
DELISTED
Lydall, Inc.
LDL
$1.87M 0.31%
+62,414
New +$1.5M
QNST icon
142
QuinStreet
QNST
$1.2B
$1.87M 0.31%
+87,043
New +$1.59M
ROG icon
143
Rogers Corp
ROG
$2.39B
$1.86M 0.3%
+11,982
New +$1.59M
IESC icon
144
IES Holdings
IESC
$15.6B
$1.86M 0.3%
40,390
+539
+1% +$21.1K
STRO icon
145
Sutro Biopharma
STRO
$424M
$1.86M 0.3%
+8,553
New +$1.42M
RVLV icon
146
Revolve Group
RVLV
$1.74B
$1.85M 0.3%
+59,349
New +$1.32M
PD icon
147
PagerDuty
PD
$890M
$1.85M 0.3%
+44,336
New +$1.51M
RRX icon
148
Regal Rexnord
RRX
$11.9B
$1.85M 0.3%
+15,059
New +$1.66M
GPRO icon
149
GoPro
GPRO
$122M
$1.84M 0.3%
+222,326
New +$1.6M
ADNT icon
150
Adient
ADNT
$1.5B
$1.84M 0.3%
+52,910
New +$1.49M

Similar funds

EAM Investors's Q4 2020 Portfolio in Review

As of Q4 2020, EAM Investors held 440 positions worth $611M, up 45% from $422M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors's Q4 2020 filing shows 177 new, 32 increased, 81 reduced and 148 closed positions. Its largest new stake was Callaway Golf Company: 338,637 shares worth $8.13M. The largest sale was Cardiff Oncology, an estimated $5.05M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

  • EAM Investors's largest Q4 2020 buy was Callaway Golf Company: 338,637 shares worth $8.13M.
  • EAM Investors added most to Artisan Partners in Q4 2020, an estimated $5.25M increase.
  • EAM Investors's biggest Q4 2020 reduction was Cardiff Oncology, cutting an estimated $5.05M.
  • EAM Investors fully exited Workhorse Group in Q4 2020, selling an estimated $4.62M.
  • EAM Investors's ten largest holdings make up 10% of its $611M portfolio in Q4 2020.
  • EAM Investors opened 177 new positions and closed 148 in Q4 2020.
  • EAM Investors's portfolio value rose 45% quarter-over-quarter to $611M.

Based on EAM Investors's 13F filing for Q4 2020, filed 11 Feb 2021.